COVID Risk | Literature database and meta-analysis page 15

Last update : 2021-08-05 08:37:15 (GMT+2) | 276 factors investigated | 1766 estimates included | 219 articles processed | QC progress: 50%

Receive updates on COVID-19 risk factors

Associated factors

Risk category:

Risk name:

Outcomes

Outcome description:

Filters

Adjusted analysis:

Author:

Reset
Run a meta-analysis by selecting an Outcome & a Risk category or a Risk name & a Risk category, and click on the Submit button.

Green: significant protective factor
Red: significant risk factor
^§ adjusted estimate (see article details)
^† estimated using data reported in the article

Outcome	Risk category	Risk [exposed vs. unexposed]	Risk estimate (95% CI)	Author [URL]	View	QC
COVID-19 (severe/fatal)	Laboratory Findings	LDH [Abnormal vs. Normal]	Odds ratio: 8.860 (2.720-28.890)	Zheng
COVID-19 (severe/fatal)	Laboratory Findings	Procalcitonin [Abnormal vs. Normal]	Odds ratio: 8.210 (1.920-35.050)	Zheng
COVID-19 (severe/fatal)	Laboratory Findings	HS-cTnI [Abnormal vs. Normal]	Odds ratio: 43.240 (9.920-188.490)	Zheng
COVID-19 (severe/fatal)	Laboratory Findings	Creatinine [Abnormal vs. Normal]	Odds ratio: 5.300 (2.190-12.830)	Zheng
COVID-19 (severe/fatal)	Laboratory Findings	AST [Abnormal vs. Normal]	Odds ratio: 4.000 (2.460-6.520)	Zheng
COVID-19 (severe/fatal)	Laboratory Findings	WBC [Abnormal vs. Normal]	Odds ratio: 0.300 (0.170-0.510)	Zheng
COVID-19 (severe/fatal)	Symptoms	Shortness of breath [Present vs. Not present]	Odds ratio: 4.160 (3.100-5.530)	Zheng
COVID-19 (severe/fatal)	Symptoms	Nausea/vomiting [Present vs. Not present]	Odds ratio: 1.320 (0.720-2.420)	Zheng
COVID-19 (severe/fatal)	Symptoms	Diarrhea [Present vs. Not present]	Odds ratio: 1.410 (0.820-2.430)	Zheng
COVID-19 (severe/fatal)	Symptoms	Fatigue [Present vs. Not present]	Odds ratio: 1.130 (0.880-1.440)	Zheng
COVID-19 (severe/fatal)	Symptoms	Sputum production [Present vs. Not present]	Odds ratio: 1.140 (0.840-1.540)	Zheng
COVID-19 (severe/fatal)	Symptoms	Cough [Present vs. Not present]	Odds ratio: 1.080 (0.850-1.380)	Zheng
COVID-19 (severe/fatal)	Symptoms	Myalgia/Arthralgia [Present vs. Not present]	Odds ratio: 0.770 (0.580-1.040)	Zheng
COVID-19 (severe/fatal)	Symptoms	Headache [Present vs. Not present]	Odds ratio: 0.820 (0.500-1.360)	Zheng
COVID-19 (severe/fatal)	Symptoms	Fever [Present vs. Not present]	Odds ratio: 0.560 (0.380-0.820)	Zheng
COVID-19 (severe/fatal)	Comorbidities	Hypertension [Present vs. Not present]	Odds ratio: 2.720 (1.600-4.640)	Zheng
COVID-19 (severe/fatal)	Comorbidities	Cancer [Present vs. Not present]	Odds ratio: 1.600 (0.810-3.180)	Zheng
COVID-19 (severe/fatal)	Comorbidities	Respiratory disease [Present vs. Not present]	Odds ratio: 5.150 (2.510-10.570)	Zheng
COVID-19 (severe/fatal)	Comorbidities	Cardiovascular disease [Present vs. Not present]	Odds ratio: 5.190 (3.250-8.290)	Zheng
COVID-19 (severe/fatal)	Comorbidities	Diabetes [Present vs. Not present]	Odds ratio: 3.680 (2.680-5.030)	Zheng
COVID-19 (severe/fatal)	Patient characteristics	Smoking [Present vs. Not present]	Odds ratio: 2.040 (1.320-3.150)	Zheng
COVID-19 (severe/fatal)	Patient characteristics	Gender [Male vs. Female]	Odds ratio: 1.770 (1.430-2.190)	Zheng
COVID-19 (severe/fatal)	Patient characteristics	Age [>65 years vs. <=65 years]	Odds ratio: 6.010 (3.950-9.160)	Zheng
COVID-19 (death)	Treatment	Treatment for COVID-19 [High dosage chloroquine diphosphate vs. Low dosage chloroquine diphosphate]	Odds ratio: 2.800 (0.900-8.500) ^§	Borba
COVID-19 (death)	Treatment	Treatment for COVID-19 [High dosage chloroquine diphosphate vs. Low dosage chloroquine diphosphate]	Odds ratio: 3.600 (1.200-10.600)	Borba
COVID-19 (clinical improvement)	Treatment	Treatment for COVID-19 [Treated with Lopinavir–Ritonavir vs. Standard Care]	Hazard ratio: 1.240 (0.900-1.720)	Cao
Virus clearance	Comorbidities	Any comorbidity [Present vs. Not present]	Hazard ratio: 0.456 (0.064-3.275) ^§	Cai
Virus clearance	Patient characteristics	Age [1 year increase vs. Not applicable]	Hazard ratio: 1.000 (0.971-1.029) ^§	Cai
Virus clearance	Treatment	Treatment for COVID-19 [Treated with favipiravir vs. Treated with lopinavir/ritonavir]	Hazard ratio: 3.434 (1.162-10.148) ^§	Cai
Virus clearance	Status	Time from onset to treatment [1 day increase vs. Not applicable]	Hazard ratio: 1.217 (0.996-1.486) ^§	Cai
Virus clearance	Laboratory Findings	CD8 [1 unit increase vs. Not applicable]	Hazard ratio: 0.997 (0.993-1.002) ^§	Cai
Virus clearance	Laboratory Findings	T lymphocyte [1 unit increase vs. Not applicable]	Hazard ratio: 1.002 (1.000-1.005) ^§	Cai
Virus clearance	Laboratory Findings	Neutrophils [1 unit increase vs. Not applicable]	Hazard ratio: 2.236 (0.617-8.105) ^§	Cai
Virus clearance	Laboratory Findings	Platelet count [1 unit increase vs. Not applicable]	Hazard ratio: 1.011 (0.998-1.024) ^§	Cai
Virus clearance	Laboratory Findings	Hemoglobin [1 unit increase vs. Not applicable]	Hazard ratio: 1.002 (0.969-1.036) ^§	Cai
Virus clearance	Laboratory Findings	WBC [1 unit increase vs. Not applicable]	Hazard ratio: 0.421 (0.129-1.368) ^§	Cai
COVID-19 (death)	Laboratory Findings	NK-cell [1 unit increase vs. Not applicable]	Odds ratio: 0.990 (0.980-0.990)	Xu
COVID-19 (death)	Laboratory Findings	B-cell [1 unit increase vs. Not applicable]	Odds ratio: 0.990 (0.980-0.990)	Xu
COVID-19 (death)	Laboratory Findings	CD8 [1 unit increase vs. Not applicable]	Odds ratio: 0.980 (0.970-0.990)	Xu
COVID-19 (death)	Laboratory Findings	CD4 [1 unit increase vs. Not applicable]	Odds ratio: 0.990 (0.980-0.990)	Xu
COVID-19 (death)	Laboratory Findings	CD3 [1 unit increase vs. Not applicable]	Odds ratio: 0.990 (0.980-0.990)	Xu
COVID-19 (death)	Laboratory Findings	Lymphocytes [Abnormal vs. Normal]	Odds ratio: 11.610 (4.670-30.900)	Xu
COVID-19 (death)	Laboratory Findings	Lymphocytes [1 unit increase vs. Not applicable]	Odds ratio: 0.994 (0.992-0.997)	Xu
COVID-19 (severe/fatal)	Comorbidities	Non-alcoholic fatty liver disease [Present vs. Not present]	Odds ratio: 6.400 (1.500-31.200) ^§	Ji
COVID-19 (severe/fatal)	Comorbidities	Any comorbidity [Present vs. Not present]	Odds ratio: 6.300 (2.300-18.800) ^§	Ji
COVID-19 (severe/fatal)	Patient characteristics	BMI [1 unit increase vs. Not applicable]	Odds ratio: 1.300 (1.000-1.800) ^§	Ji
COVID-19 (severe/fatal)	Patient characteristics	Gender [Male vs. Female]	Odds ratio: 3.100 (1.100-9.400) ^§	Ji
COVID-19 (severe/fatal)	Patient characteristics	Age [>60 years vs. <=60 years]	Odds ratio: 4.800 (1.500-16.200) ^§	Ji
SARS COV-2 infection	Symptoms	Body aches [Present vs. Not present]	Odds ratio: 3.100 (1.400-7.000) ^§	Roland
SARS COV-2 infection	Symptoms	Sore throat [Present vs. Not present]	Odds ratio: 0.300 (0.200-0.600) ^§	Roland

If a relevant publication escaped our attention, please contact us.